Kate Haviland

CHIEF EXECUTIVE OFFICER

Kate Haviland (CHIEF EXECUTIVE OFFICER) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in BPMC. The largest single filing was $1.4M of BPMC (16,151 sh × $88.80, as filed), executed Mar 5 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.9M

shares × price, as filed

Last traded

Apr 1 2025

Filed Apr 3 2025

Open performance→

Volume by month

Buys $0 Sells $1.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 4 filings

Sector per market data · by filing · past 24 months

Most traded names

BPMC BPMC BPMC · 0 buys · 4 sells 4 filings

Recent filings

BPMCSALE Blueprint Medicines Corp View filing → $105K
1,200 sh × $87.34
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $1.4M
16,151 sh × $88.80
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $159K
1,446 sh × $110.24
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $169K
1,746 sh × $96.74
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET